Evidence map›Paper›PMID 42760561›Full record

ArticleActa neuropathologica communications2026

Experimental induction of myelin damage in post-mortem human brain slice cultures.

Niels Reinder Coenraad Meijns, Gema Muñoz González, Sabine Stolker, Bert T Hart, Bonnie C Plug, Marianna Bugiani, Anita Grootemaat, Nicole van der Wel, Öznur Bilir, Kasra Roya-Kouchaki and 7 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Niels Reinder Coenraad Meijns *Department of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Gema Muñoz González *Department of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Sabine StolkerDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Bert T HartDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Bonnie C PlugAmsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Marianna BugianiAmsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Anita GrootemaatAmsterdam UMC, Medical Biology, Electron Microscopy Center Amsterdam, Amsterdam, The Netherlands.
Nicole van der WelAmsterdam UMC, Medical Biology, Electron Microscopy Center Amsterdam, Amsterdam, The Netherlands.
Öznur BilirDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Kasra Roya-KouchakiDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Wulin TeoDepartment of Clinical Neurosciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary AB, Canada.
Peter K StysDepartment of Clinical Neurosciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary AB, Canada.
Sophie HillSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
Geert J SchenkDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands.
Gijs KooijAmsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Ben NewlandSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
Antonio LuchicchiDepartment of Anatomy and Neurosciences, MS Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam Neuroscience, 1081 HZ, Amsterdam, The Netherlands. a.luchicchi@amsterdamumc.nl.

Funding

Academy of Medical Sciences Springboard Fund-SBF006/1083Dutch National MS Society Research grant OZ2021-008National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/W000989/1Progressive MS Alliance PA2021-36033Stichting MS Research 24-1223 MS
6 · The paper itself

Abstract

The mechanisms that drive myelin damage as seen in demyelinating disorders such as multiple sclerosis remain incompletely understood. Much of our current knowledge is derived from animal models, but interspecies differences limit their relevance in the context of human pathology and could explain why various promising therapies failed during clinical translation. Human post-mortem organotypic brain slice cultures provide a unique platform to study human myelin biology, as they preserve genetic, cytoarchitectural, pathological and species-specific context. Here, we evaluated myelin integrity in a human post-mortem organotypic brain slice culture model and experimentally induced focal myelin damage. Human post-mortem organotypic brain slice cultures retain key features throughout the culturing period, but exhibit gradual cellular and myelin loss over time. Myelin fibres within the white matter remain detectable and display preserved structural and chemical integrity up to 13 days in vitro, as indicated by the conserved ultrastructure, paranodal and nodal organization, and stable myelin spectroscopic signature. Topical delivery of lysophosphatidylcholine using cryogel scaffolds enables focal drug administration throughout the full depth of the slice with minimal diffusion into surrounding tissue and induces localized demyelination. Similar focal application of β-scorpion toxin Cn2, a Na

Indexed as

BrainDemyelinating DiseasesMyelin SheathAgedAged, 80 and overFemaleHumansLysophosphatidylcholinesMaleMiddle AgedOrgan Culture TechniquesLysophosphatidylcholinesCryogelDemyelinationHumanMyelinOrganotypic slice cultureTranslational model

Identifiers

PMID42760561
PMCPMC13589377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.